Texas Permanent School Fund Corp Sells 154 Shares of Humana Inc. (NYSE:HUM)

Texas Permanent School Fund Corp reduced its position in shares of Humana Inc. (NYSE:HUM) by 0.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 25,267 shares of the insurance provider’s stock after selling 154 shares during the quarter. Texas Permanent School Fund Corp’s holdings in Humana were worth $8,761,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of HUM. Norges Bank purchased a new stake in Humana in the fourth quarter worth $676,800,000. Sanders Capital LLC purchased a new stake in Humana in the fourth quarter worth $489,300,000. Putnam Investments LLC increased its stake in Humana by 550.3% in the fourth quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock worth $400,808,000 after purchasing an additional 740,858 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Humana by 255.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 620,793 shares of the insurance provider’s stock worth $215,241,000 after purchasing an additional 446,124 shares during the period. Finally, Pzena Investment Management LLC increased its stake in Humana by 36,975.8% in the first quarter. Pzena Investment Management LLC now owns 362,972 shares of the insurance provider’s stock worth $125,850,000 after purchasing an additional 361,993 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on HUM shares. Royal Bank of Canada dropped their price target on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Piper Sandler started coverage on Humana in a research report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price target on the stock. Bank of America increased their price target on Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research report on Monday, May 20th. The Goldman Sachs Group dropped their price target on Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $360.00 price target on shares of Humana in a research report on Wednesday, June 12th. Fourteen equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $409.55.

Humana Stock Performance

HUM stock traded up $0.56 during trading on Thursday, hitting $379.73. 830,069 shares of the company traded hands, compared to its average volume of 1,777,955. The stock’s 50-day simple moving average is $354.15 and its 200 day simple moving average is $347.04. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The company has a market cap of $45.76 billion, a PE ratio of 23.64, a P/E/G ratio of 2.14 and a beta of 0.51. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business’s revenue was up 10.7% compared to the same quarter last year. During the same period in the previous year, the business earned $9.38 earnings per share. On average, equities analysts expect that Humana Inc. will post 16.27 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.93%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.